Novavax stock (NVAX) skyrocketed Friday, up 120% on the news that French drug and vaccine giant Sanofi (SNY) is investing $1.2 billion in a deal for Novavax's COVID-19 vaccine as well as a ...

Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, the company’s earnings beat estimates by 12.64%. The Zacks Consensus ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and twelve months ended December 31, 2024. Novavax, Inc. (Nasdaq: NVAX), a ...

Listen to this discussion on SBS Sinhala Radio to find out how the Novavax vaccine differs from ... Ease into the English language and Australian culture. We make learning English convenient ...

Bullish option flow detected in Novavax (NVAX) with 23,789 calls trading, 3x expected, and implied vol increasing over 8 points to 114.25%. Feb-25 8.5 calls and Mar-25 7.5 puts are the most active ...

Shares of Novavax declined after the company reaffirmed full-year revenue and fellow vaccine maker Moderna lowered its guidance. Novavax stock was down 7.3%, to $8.64, on Monday but is up about 89 ...

Stocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic. Novavax (NVAX) closed the most recent trading day at $7.92, moving -1.25% from the ...